Radiosynthesis and in vitro evaluation of 2-(N-alkyl-N-1'-11C-propyl)amino-5-hydroxytetralin analogs as high affinity agonists for dopamine D-2 receptors

Nuclear Medicine and Biology

Volumn 26, Issue 7, 1999, Pages 725-735

  Shi, Bingzhi ^a   Narayanan, Tanjore K ^a   Yang, Zhi Ying ^b   Christian, Bradley T ^a   Mukherjee, Jogeshwar ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Carbon 11 agonists; Dopamine D 2 receptor; In vitro autoradiography

Indexed keywords

2 DIPROPYLAMINO 5,6 DIHYDROXYTETRALIN; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT; TETRALIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BRAIN SLICE; CHROMATOGRAPHY; CONTROLLED STUDY; CORPUS STRIATUM; DRUG SYNTHESIS; DRUG TARGETING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPOPHILICITY; MALE; METHODOLOGY; NONHUMAN; RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; AUTORADIOGRAPHY; BRAIN; CARBON RADIOISOTOPES; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; ISOTOPE LABELING; MALE; PHENETHYLAMINES; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; TETRAHYDRONAPHTHALENES;

EID: 0032711218     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00051-7     Document Type: Article

References (30)

1. 11C-propionyl chloride. J. Labelled Compd. Radiopharm. 40:1997;565.
2. Chumpradit S., Kung M.-P., Foulon C., Kung H.F. (R)trans-7-OH-PIPAT A potential D3 dopamine receptor imaging agent for SPECT . J. Labelled Compd. Radiopharm. 35:1994;473-475.
3. Chumpradit S., Kung M.-P., Vessotskie J., Foulon C., Mu M., Kung H.F. Iodinated 2-aminotetralins and 3-amino-1-benzopyrans Ligands for dopamine D-2 and D-3 receptors . J. Med. Chem. 37:1994;4245-4250.
4. Cornforth J.W., Robinson R. Experiments on the synthesis of substances related to the sterols. Part XLVIII. Synthesis of a tricyclic degradation product of cholesterol. J. Chem. Soc. 1949;1855-1865.
5. Cox B.A., Henningsen R.A., Spanoyannis A., Neve R.L., Neve K.A. Contributions of conserved serine residues to the interactions of ligands with dopamine D-2 receptors. J. Neurochem. 59:1992;627-635.
6. Craig P.N. Interdependence between physical parameters and selection of substituent groups for correlation studies. J. Med. Chem. 14:1971;680-684.
7. George S.R., Watanabe M., Di Paolo T., Falardeau P., Labrie F., Seeman P. The functional state of the dopamine receptor in the anterior pituitary is in the high affinity form. Endocrinology. 117:1985;690-697.
8. Grigoriadis D., Seeman P. Complete conversion of brain D-2 dopamine receptors from the high- to low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide. J. Neurochem. 44:1985;1925-1935.
9. Hacksell U., Svensson U., Nilsson J.L.G., Hjorth S., Carlsson A., Wikstrom H., Lindberg P., Sanchez. N-Alkylated 2-aminotetralins Central dopamine receptor stimulating activity . J. Med. Chem. 22:1979;1469-1475.
10. Halldin C., Swahn C.-G., Neumeyer J.L., Hall H., Gao Y., Karlsson P., Farde L. Preparation of two potent and selective dopamine D-2 receptor agonists (R)-[propyl-C-11]-2-OH-NPA and (R)-[methyl-C-11]2-OCH3-NPA . J. Labelled Compd. Radiopharm. 32:1993;265-266.
11. Halldin C., Swahn C.-G., Suhara L., Farde L., Karlsson P., Sokoloff P., Sedvall G. Preparation of (+)-[propyl-11C]7-OH-DPAT, a selective dopamine D-3 receptor agonist for PET. J. Labelled Compd. Radiopharm. 35:1994;471-472.
12. Kung H.F., Chumpradit S., Kung M.-P., Vessotskie J., McElgin W., Mozley D., Frederick D. I-123 5-OH-PIPAT A new dopamine D3 and D2H receptor ligand for SPECT imaging . J. Nucl. Med. 35:1994;246P.
13. 125I]R(+)trans-7-OH-PIPAT in rat brain. Arch. Pharmacol. 350:1994;611-617.
14. Mansour A., Meng F., Meador-Woodruff J.H., Taylor L.P., Civelli O., Akil H. Site-directed mutagenesis of the human dopamine D-2 receptor. Eur. J. Pharmacol. 227:1992;205-214.
15. Mukherjee J. Fluorinated benzamide neuroleptics, 2. Synthesis and radiosynthesis of (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-(3[F-18]-fluoropropyl)-3-substituted-2- methoxybenzamide. Int. J. Appl. Radiat. Isotopes. 42:1991;713-721.
16. Mukherjee J., Perry B.D., Cooper M. Fluorinated benzamide neuroleptics, 1. Radiosynthesis of (S)-N-[(1-ethyl-2-pyrrolidinyl) methyl]-5-(2[F-18]-fluoroethyl)-2-methoxybenzamide A potential fluorine-18 labeled PET radiotracer for dopamine D-2 receptors . J. Labelled Compd. Radiopharm. 28:1990;609-616.
17. Munson P.J., Rodbard D. LIGAND A versatile approach for the characterisation of ligand binding systems . Anal. Biochem. 107:1980;220-239.
18. Neve K.A., Cox B.A., Henningsen R.A., Spanoyannis A., Neve R.L. Pivotal role for aspartate-80 in the regulation of dopamine D-2 receptor affinity for drugs and inhibition of adenylyl cyclase. Mol. Pharmacol. 39:1991;733-739.
19. 3H(+)PHNO. Synapse. 17:1994;167-172.
20. Rognan D., Sokoloff P., Mann A., Martres M.-P., Schwartz J.-C., Costentin J., Wermuth C.-G. Optically active benzamides as predictive tools for mapping the dopaminergic D-2 receptor. Eur. J. Pharmacol. 189:1990;59-70.
21. Roth G.S., Joseph J.A., Mason R.P. Membrane alterations as causes of impaired signal transduction in Alzheimer's disease and aging. Trends Neurosci. 18:1995;203-206.
22. Seeman P., Lee T., Chan-Wong M., Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature. 261:1976;717-719.
23. Seeman P., Ulpian C., Larsen R.D., Anderson P.S. Dopamine receptors labelled by PHNO. Synapse. 14:1993;254-262.
24. Seeman P., Watanabe M., Grigoriadis D., Tedesco J.L., George S.R., Svensson U., Nilsson J.L.G., Neumeyer J.L. Dopamine D-2 receptor binding sites for agonists A tetrahedral model . Mol. Pharmacol. 28:1986;391-399.
25. Sibley D.R., De Lean A., Creese I. Anterior pituitary dopamine receptors Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor . J. Biol. Chem. 257:1982;6351-6361.
26. 11C]-8-hydroxy-2-(di-N-propylamino)tetralin. J. Labelled Compd. Radiopharm. 35:1994;496.
27. Van der Weide J., De Vries J.B., Tepper P.G., Horn A.S. Pharmacological profiles of three new, potent and selective dopamine receptor agonists N-0434, N-0437 and N-0734 . Eur. J. Pharmacol. 125:1986;273-282.
28. Zijlstra S., Elsinga P.H., Oosterhuis E.Z., Visser G.M., Korf J., Vaalburg W. Synthesis and in vivo distribution in the rat of several fluorine-18 labeled 5-hydroxy-2-aminotetralin derivatives. Appl. Radiat. Isot. 44:1993;473-480.
29. Zijlstra S., Van der Worp H., Wiegman T., Visser G.M., Korf J., Vaalburg W. Synthesis and in vivo distribution in the rat of a dopamine agonist N-([C-11]methyl)norapomorphine . Nucl. Med. Biol. 20:1993;7-12.
30. Zijlstra S., Visser G.M., Korf J., Vaalburg W. Synthesis and in vivo distribution in the rat of several fluorine-18 labeled N-fluoroalkylapomorphines. Appl. Radiat. Isot. 44:1993;651-658.